TY  - JOUR

T1  - Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK

JO  - Current Medical Research and Opinion

PY  - 2005/05/01

AU  - Guest JF

AU  - Clegg JP

AU  - Davie AM

AU  - McCloskey E

ED  - 

DO  - DOI: 10.1185/030079905x40472

PB  - Informa Healthcare

VL  - 21

IS  - 5

SP  - 805

EP  - 815

Y2  - 2024/12/22

ER  -